A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

The results suggest the potential of semaglutide – the main ingredient in Ozempic and Novo’s higher-dose weight-loss drug ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

President Trump held a phone call today with Vladimir Putin that he described as “lengthy and highly productive.” He characterized the conversation — the first confirmed talks between the two leaders ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...

A U.S. judge ordered federal agencies to restore access to health-related webpages and datasets removed by the Trump ...

Leverage these to understand future stock performance and identify high performing investment ideas. You can also filter these to get relevant data aligned with your investing style and specific ...

50.78. On previous day, the Suzlon Energy Share Price (NSE) closed at Rs. 53.61, featuring among the most traded securities on the National Stock Exchange.